Structural basis for the selective inhibition of the PI3KC3-C2 complex by Rubicon in endolysosome maturation and mitophagy

Rubicon is a negative regulator of autophagy and the endolysosomal network (ELN) and an antagonist of the class III phosphatidylinositol 3-kinase complex II (PI3KC3-C2). Inhibition of Rubicon is considered a potential means to therapeutically upregulate autophagy and the ELN to treat Parkinson’s disease and other conditions characterized by autophagic and ELN dysfunction. Rubicon is specific for the UV radiation resistance-associated gene protein (UVRAG)-containing PI3KC3-C2 over the purely autophagic ATG14-containing PI3KC3-C1 complex. Here, we determined the high-resolution cryoelectron microscopy structure of PI3KC3-C2 in complex with the PI3KC3-binding domain of Rubicon and compared it to cryo-EM structures of unbound PI3KC3-C2 and PI3KC3-C1. Rubicon binds directly to PI3KC3-C2 only via the BARA domain of the BECN1 subunit, which is common to both C1 and C2. The selectivity of Rubicon for the PI3KC3-C2 complex over the PI3KC3-C1 complex is attributed to a conformation of the BECN1 BARA domain induced by UVRAG, rather than to direct contact with UVRAG or direct antagonism by the ATG14 subunit of PI3KC3-C1. Targeted disruption of the Rubicon:PI3K3-C2 structural interface by site-directed mutations enhances mitophagic activity in human epithelial cells to levels comparable to those observed in Rubicon knockout cells. Similarly, disruption of the interaction in Rubicon-overexpressing hippocampal neurons restored lysosomal flux to wild-type levels. These data show that suppressing the function of PI3K3-C2 can fully account for the negative regulatory effects of Rubicon in the autophagy and ELN pathways.

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2026-11-18
DOI
https://doi.org/10.1073/pnas.2628364123
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Structural basis for the selective inhibition of the PI3KC3-C2 complex by Rubicon in endolysosome maturation and mitophagy

Ian G. Ganley, Minghao Chen, Julia F. Riley, Qingyang Ni et al.
Proceedings of the National Academy of Sciences
Autophagy in Disease and Therapy
article

Structural basis for the selective inhibition of the PI3KC3-C2 complex by Rubicon in endolysosome maturation and mitophagy

Ian G. Ganley, Minghao Chen, Julia F. Riley, Qingyang Ni, Aaron M.N. Joiner, Aniketh Bishnu, James H. Hurley, Erika L.F. Holzbaur, Yongjia Duan, Isaac J. Allen
article en

Abstract

Rubicon is a negative regulator of autophagy and the endolysosomal network (ELN) and an antagonist of the class III phosphatidylinositol 3-kinase complex II (PI3KC3-C2). Inhibition of Rubicon is considered a potential means to therapeutically upregulate autophagy and the ELN to treat Parkinson’s disease and other conditions characterized by autophagic and ELN dysfunction. Rubicon is specific for the UV radiation resistance-associated gene protein (UVRAG)-containing PI3KC3-C2 over the purely autophagic ATG14-containing PI3KC3-C1 complex. Here, we determined the high-resolution cryoelectron microscopy structure of PI3KC3-C2 in complex with the PI3KC3-binding domain of Rubicon and compared it to cryo-EM structures of unbound PI3KC3-C2 and PI3KC3-C1. Rubicon binds directly to PI3KC3-C2 only via the BARA domain of the BECN1 subunit, which is common to both C1 and C2. The selectivity of Rubicon for the PI3KC3-C2 complex over the PI3KC3-C1 complex is attributed to a conformation of the BECN1 BARA domain induced by UVRAG, rather than to direct contact with UVRAG or direct antagonism by the ATG14 subunit of PI3KC3-C1. Targeted disruption of the Rubicon:PI3K3-C2 structural interface by site-directed mutations enhances mitophagic activity in human epithelial cells to levels comparable to those observed in Rubicon knockout cells. Similarly, disruption of the interaction in Rubicon-overexpressing hippocampal neurons restored lysosomal flux to wild-type levels. These data show that suppressing the function of PI3K3-C2 can fully account for the negative regulatory effects of Rubicon in the autophagy and ELN pathways.

Proceedings of the National Academy of SciencesVol. 123(47)
QB3 (US), University of Dundee (GB), MRC Protein Phosphorylation and Ubiquitylation Unit (GB), Aligning Science Across Parkinson's (US), University of Pennsylvania (US), Medical Research Council (GB), University of California, Berkeley (US)
Michael J. Fox Foundation for Parkinson's Research, Aligning Science Across Parkinson’s, National Institutes of Health, National Institute of Neurological Disorders and Stroke
Good health and well-being
Autophagy in Disease and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon